Skip to content
Screener

Globus Medical GMED Q1 2025 earnings

Reported May 8, 2025 · After market close

Revenue$598.1MMiss by $27.8M
EPS$0.68Miss by $0.06
Revenue estimate$625.9M
EPS estimate$0.74

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$792.2M
EPS estimate$1.20

Financials

Q1 2025

Income statement

See full
Revenue$598.1M-1.4%
Gross profit$402.7M+10.3%
Operating income$97.0M+1,113%
Net income$75.5M+1,160%
EPS (diluted)$0.54+1,180%

Balance sheet

See full
Cash & equivalents$461.3M+30.3%
Total debt$93.0M-9.4%
Total equity$4.1B+4.2%
Total assets$4.7B-4.7%

Cash flow

See full
Operating cash flow$177.3M+238%
CapEx$36.1M+26.4%
Free cash flow$141.2M+493%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$10.07B+38.7%
Enterprise value$9.7B+38.4%
P/E54.3×-54.7×
P/S+0.2×

Profitability

See full
Gross margin60.6%-1.5pp
Operating margin10.2%+5.7pp
Net margin7.4%+3.9pp
FCF margin20.8%+12.8pp

Returns & leverage

See full
Return on equity4.6%+2.4pp
Debt / equity0.0×
Current ratio4.4×+2.1×

Segments

By segment

See full
Reportable Segment$598.1M-5.0%

FAQ

When did Globus Medical report Q1 2025 earnings?
Globus Medical (GMED) reported Q1 2025 earnings on May 8, 2025 after market close.
What were Globus Medical's Q1 2025 revenue and EPS?
Globus Medical reported revenue of $598.1M and eps of $0.68 for Q1 2025.
Did Globus Medical beat estimates in Q1 2025?
Revenue missed the consensus estimate of $625.9M by $27.8M. EPS missed the consensus estimate of $0.74 by $0.06.
How did Globus Medical's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.4% from $606.7M a year earlier and eps declined 5.6% from $0.72.
Where can I find Globus Medical's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001562762-25-000114) and the 10-Q periodic report (0001562762-25-000118) directly on SEC EDGAR. The filing index links above go to sec.gov.